中药多酚在肺纤维化中的分子机制与治疗靶点
本文综述肺纤维化的经典机制及新兴机制,并汇总白藜芦醇、姜黄素、丹酚酸B、表没食子儿茶素-3-没食子酸酯、没食子酸和柯里拉京等多酚类化合物通过调控氧化应激、炎症、自噬、凋亡和焦亡等途径发挥抗肺纤维化作用的证据,探讨其分子机制与治疗靶点。
要点
- 多酚类化合物可同时调控氧化应激、炎症、自噬、凋亡和焦亡等多个因素。
- 不同酚类化合物抗肺纤维化的机制和信号通路并不相同。
- 中药多酚具有抑制持续纤维化并促进现有纤维化消退的潜力。
核心结论
- 中药多酚作为多靶点药物在肺纤维化治疗中具有良好潜力。
- 酚类化合物可同时调控氧化应激、炎症、自噬、凋亡和焦亡等多个因素以减轻肺纤维化损伤。
- 不同酚类化合物抗肺纤维化机制各异,涉及的信号通路不尽相同。
研究设计与样本
- 本文为综述,回顾了肺纤维化的经典机制及用于研究肺疾病病理复杂网络的新兴机制。
- 综述汇总了来源于水果、茶和草药的酚类化合物抗肺纤维化相关研究进展。
主要发现
- 氧化应激和免疫/炎症等因素参与慢性肺病关键病理过程,其相互作用介导慢性肺损伤、肺泡上皮剥脱、II型肺泡上皮细胞过度增殖、成纤维细胞增殖分化及微血管通透性改变。
- 白藜芦醇、姜黄素、丹酚酸B、表没食子儿茶素-3-没食子酸酯、没食子酸和柯里拉京等酚类化合物具有同时调控多个因素的生物活性。
- 每种酚类化合物可通过多种机制发挥抗肺纤维化效应。
临床怎么用
- 中药多酚可作为抗肺纤维化多靶点治疗的候选化合物,但临床应用需基于进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary fibrosis (PF) is a highly confounding and fatal pathological process with finite treatment options. Multiple factors such as oxidative and immune/inflammation involve key pathological processes in chronic lung disease, and their intimate interactions mediate chronic lung damage, denudation of the alveolar epithelium, hyperproliferation of type II alveolar epithelial cells (AECIIs), proliferation and differentiation of fibroblasts, and the permeability of microvessels. We reviewed the classic mechanism of PF and highlighted a few emerging mechanisms for studying complex networks in lung disease pathology. Polyphenols, as a multi-target drug, has excellent potential in the treatment of pulmonary fibrosis. We then reviewed recent advances in discovering phenolic compounds from fruits, tea, and medical herbs with the bioactivities of simultaneously regulating multiple factors (e.g., oxidative stress, inflammation, autophagy, apoptosis, pyroptosis) for minimizing pulmonary fibrosis injury. These compounds include resveratrol, curcumin, salvianolic acid B, epigallocatechin-3-gallate, gallic acid, corilagin. Each phenolic compound can exert its anti-PF effect through various mechanisms, and the signaling pathways involved in different phenolic compounds are not the same. This review summarized the available evidence on phenolic compounds' effectiveness in pulmonary diseases and explored the molecular mechanisms and therapeutic targets of phenolic compounds from Chinese herbal medicine with the properties of inhibition of ongoing fibrogenesis and resolution of existing fibrosis.
引用
- Wang L, Zhu T, Feng D, et al. Polyphenols from Chinese Herbal Medicine: Molecular Mechanisms and Therapeutic Targets in Pulmonary Fibrosis. Am J Chin Med. 2022. PMID: 35475972. doi:10.1142/S0192415X22500434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。